BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

37 related articles for article (PubMed ID: 8002991)

  • 1. Structural basis for abrogated binding between staphylococcal enterotoxin A superantigen vaccine and MHC-IIalpha.
    Krupka HI; Segelke BW; Ulrich RG; Ringhofer S; Knapp M; Rupp B
    Protein Sci; 2002 Mar; 11(3):642-51. PubMed ID: 11847286
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Crystal structure of staphylococcal enterotoxin G (SEG) in complex with a mouse T-cell receptor {beta} chain.
    Fernández MM; Cho S; De Marzi MC; Kerzic MC; Robinson H; Mariuzza RA; Malchiodi EL
    J Biol Chem; 2011 Jan; 286(2):1189-95. PubMed ID: 21059660
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of a transcytosis epitope on staphylococcal enterotoxins.
    Shupp JW; Jett M; Pontzer CH
    Infect Immun; 2002 Apr; 70(4):2178-86. PubMed ID: 11895985
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Putative staphylococcal enterotoxin possesses two common structural motifs for MHC-II binding.
    Rahman S; Saha S; Dasgupta SB; Das AK
    Int J Biol Macromol; 2024 Jan; 256(Pt 1):128437. PubMed ID: 38013079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure of the staphylococcal enterotoxin B vaccine candidate S19 showing eliminated superantigen activity.
    Jeong WH; Song DH; Hur GH; Jeong ST
    Acta Crystallogr F Struct Biol Commun; 2017 Nov; 73(Pt 11):595-600. PubMed ID: 29095152
    [TBL] [Abstract][Full Text] [Related]  

  • 6. De novo design of a protein binder against Staphylococcus enterotoxin B.
    Ming K; Xing B; Hu Y; Mei M; Huang W; Hu X; Wei Z
    Int J Biol Macromol; 2024 Feb; 257(Pt 1):128666. PubMed ID: 38070805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of nanobodies against Staphylococcus enterotoxin B through yeast surface display.
    Ming K; Hu Y; Zhu M; Xing B; Mei M; Wei Z
    Int J Biol Macromol; 2023 Dec; 253(Pt 2):126822. PubMed ID: 37703983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In Silico Design and Analysis of TGFαL3-SEB Fusion Protein as "a New Antitumor Agent" Candidate by Ligand-Targeted Superantigens Technique.
    Imani-Fooladi AA; Yousefi F; Mousavi SF; Amani J
    Iran J Cancer Prev; 2014; 7(3):152-64. PubMed ID: 25250167
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of bacterial superantigens by peptides and antibodies.
    Visvanathan K; Charles A; Bannan J; Pugach P; Kashfi K; Zabriskie JB
    Infect Immun; 2001 Feb; 69(2):875-84. PubMed ID: 11159981
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Localization of a T-cell epitope of superantigen toxic shock syndrome toxin 1 to residues 125 to 158.
    Hu WG; Zhu XH; Wu YZ; Jia ZC
    Infect Immun; 1998 Oct; 66(10):4971-5. PubMed ID: 9746605
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The potential role of superantigens in inflammatory bowel disease.
    Kay RA
    Clin Exp Immunol; 1995 Apr; 100(1):4-6. PubMed ID: 7697920
    [No Abstract]   [Full Text] [Related]  

  • 12. A natural mutation of the amino acid residue at position 60 destroys staphylococcal enterotoxin A murine T-cell mitogenicity.
    Mahana W; al-Daccak R; Lévéillé C; Valet JP; Hébert J; Ouellette M; Mourad W
    Infect Immun; 1995 Aug; 63(8):2826-32. PubMed ID: 7622202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of binding domains on the superantigen, toxic shock syndrome-1, for class II MHC molecules.
    Soos JM; Russell JK; Jarpe MA; Pontzer CH; Johnson HM
    Biochem Biophys Res Commun; 1993 Mar; 191(3):1211-7. PubMed ID: 8466498
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The crystal structure of staphylococcal enterotoxin H: implications for binding properties to MHC class II and TcR molecules.
    Hâkansson M; Petersson K; Nilsson H; Forsberg G; Björk P; Antonsson P; Svensson LA
    J Mol Biol; 2000 Sep; 302(3):527-37. PubMed ID: 10986116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Major histocompatibility complex class II-associated peptides determine the binding of the superantigen toxic shock syndrome toxin-1.
    von Bonin A; Ehrlich S; Malcherek G; Fleischer B
    Eur J Immunol; 1995 Oct; 25(10):2894-8. PubMed ID: 7589089
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rules governing peptide-class II MHC molecule interactions.
    Hammer J; Nagy ZA; Sinigaglia F
    Behring Inst Mitt; 1994 Jul; (94):124-32. PubMed ID: 7998906
    [No Abstract]   [Full Text] [Related]  

  • 17. Superantigens. Gazing into the crystal ball.
    Hsu PN; Huber BT
    Curr Biol; 1995 Mar; 5(3):235-7. PubMed ID: 7780728
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiple binding sites on the superantigen, staphylococcal enterotoxin B, imparts versatility in binding to MHC class II molecules.
    Soos JM; Johnson HM
    Biochem Biophys Res Commun; 1994 Jun; 201(2):596-602. PubMed ID: 8002991
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.